Income Tax Examination, Period after Filing Income Tax Returns Subject to Examination
Period after filing income tax returns subject to examination
Represents the period after filing income tax returns subject to examination by the taxing authority.
Document and Entity Information
Cash contributed by S.R. Burzynski, M.D., Ph.D. and related parties
Adjustments to Additional Paid in Capital, Cash Contributed
Represents the cash contributed by the individual that is reported as additional paid-in capital, which is used to fund general operating expenses during the reporting year.
FDA clinical trial expenses paid directly by S.R. Burzynski, M.D., Ph.D.
Adjustments to Additional Paid in Capital, Clinical Trial Expenses
Represents the clinical trial expenses that are incurred by the entity during the research process for treatment of cancer. These expenses have been reported as research and development costs and as additional paid-in capital during the reporting period.
FDA clinical trial expenses paid directly by S.R. Burzynski, M.D., Ph.D.
Represents the clinical trial expenses that are incurred by the entity which are used in the treatment of cancer during the reporting period.
Clinical Trial Expenses Paid
Cash Paid During the Year for
Cash Paid During the Year For:
Award Type [Axis]
Ownership Interest Percentage Held By Company President And Chairman Of Board
Percentage of outstanding stock owned by the President and Chairman of the Board
Represents the percentage interest of ownership held by the President of the Company, whom is also the Chairman of the Board.
The number of share-based compensation plans approved by the entity's shareholders.
Share Based Compensation Arrangement, by Share Based Payment Award, Number of Plans
Number of share-based compensation plans
Vested (in shares)
Represents the number of options vested during the reporting period.
Share Based Compensation Arrangement, by Share Based Payment Award, Options Vested in Period
Share Based Compensation Arrangement, by Share Based Payment Award, Options Period for which Awards Increase Proportionately to New Issues
Period from the grant dates for which the awards increase in the same percentage of any new shares of stock issued
Represents the period for which the number of share options (or share units) increase proportionately of any new shares of stock issued during the period.
Amendment Description
Worldwide Medical Consultants Inc [Member]
Worldwide Medical Consultants, Inc. ("WMC")
Represents information pertaining to Worldwide Medical Consultants Inc.
Amendment Flag
Carigen Ltd [Member]
CARIGEN, LTD ("SRB")
Represents information pertaining to Carigen Ltd., an entity wholly owned and controlled by Dr. Burzynski.
Percentage of Consulting Fee to be Received as Per Agreement
Consulting fee (as a percent)
Represents the percentage of consulting fee to be received by the Company per the marketing agreement.
Class of Warrant or Right Number of Securities to be Called by Warrants or Rights WMC Payment Consideration
Warrants to be granted to acquire shares of common stock (in shares)
Represents the warrants to be granted by the Company to acquire shares of common stock. This represents the consideration for the WMC payment per the marketing agreement.
Class of Warrant or Rights Exercise Period
Warrants exercise period
Represents the exercise period for warrants exercisable.
Shares Vesting Upon Execution of Agreement
Shares vesting upon execution of the agreement
Represents the shares vesting upon execution of the agreement.
Remaining Shares to Vest Upon First Closing of Agreement
Remaining shares to vest upon the first closing of a transaction by SRB under the marketing agreement
Represents the remaining shares to vest upon the first closing of a transaction by SRB as a result of the services provided by WMC under the marketing agreement.
Marketing Agreement [Abstract]
Marketing Agreement
Warrants Or Rights Fair Value
Fair value of vested warrants at date of grant
Represents the fair value of warrants or rights at the date of grant.
Warrant Or Right Fair Value Per Warrant
Fair value of vested warrants at date of grant (in dollars per share)
Represents the fair value of warrants or rights per share at the date of grant.
Shares Nonvested as Result of Closing of Transaction
Shares that did not vest as a result of a closing of transaction
Represents the shares that did not vest as a result of a closing of transaction, as of the reporting date.
Current Fiscal Year End Date
Document Period End Date
Entity [Domain]
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Filer Category
Entity Public Float
Entity Registrant Name
Entity Central Index Key
Entity Common Stock, Shares Outstanding
Document Fiscal Year Focus
Document Fiscal Period Focus
Legal Entity [Axis]
Document Type
Accounts Payable, Current
Accounts payable
Accrued Liabilities, Current
Accrued liabilities
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Property and equipment, accumulated depreciation (in dollars)
Additional Paid in Capital, Common Stock
Additional paid-in capital
Additional Paid-in Capital [Member]
Additional Paid-in Capital
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used by operating activities:
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Warrants and stock options excluded from calculation of diluted loss per share
Assets, Current [Abstract]
Current assets
Assets [Abstract]
ASSETS
Assets, Current
TOTAL CURRENT ASSETS
Assets
TOTAL ASSETS
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents
CASH AT BEGINNING OF PERIOD
CASH AT END OF PERIOD
Exercisable price (in dollars per share)
Class of Warrant or Right, Exercise Price of Warrants or Rights
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies and Supply Source:
Commitments and Contingencies and Supply Source:
Commitments and Contingencies
Commitments and contingencies
Common Stock [Member]
Common Stock
Common Stock, Shares, Outstanding
Common stock, shares outstanding
Common Stock, Value, Issued
Common stock, $.001 par value; 200,000,000 shares authorized; 131,448,444 issued and outstanding at November 30, 2012 and February 29, 2012, respectively
Common Stock, Shares, Issued
Common stock, shares issued
Common Stock, Par or Stated Value Per Share
Common stock, par value (in dollars per share)
Common Stock, Shares Authorized
Common stock, shares authorized
Compensation Related Costs, General [Text Block]
Employee Benefits:
Employee Benefits:
Net deferred tax asset
Deferred Tax Assets, Net of Valuation Allowance
Deferred tax asset
Deferred Tax Assets, Net [Abstract]
Valuation allowance
Deferred Tax Assets, Valuation Allowance
Depreciation, Depletion and Amortization
Depreciation
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
STOCK OPTIONS
STOCK OPTIONS
Earnings Per Share, Basic and Diluted
Basic and diluted loss per common share (in dollars per share)
LOSS PER SHARE
Earnings Per Share [Text Block]
LOSS PER SHARE
Loss per share information:
Loss Per Share
U.S. federal income tax rate (as a percent)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate
Equity Component [Domain]
General and Administrative Expense
General and administrative
STATEMENTS OF OPERATIONS
Income Tax Disclosure [Text Block]
INCOME TAXES
INCOME TAXES
Income Tax Authority [Axis]
Income Taxes
Income Tax Examination [Line Items]
Income Tax Authority [Domain]
Actual provision for income tax
Income Tax Expense (Benefit), Continuing Operations [Abstract]
Income tax expense
Income Tax Expense (Benefit)
Provision for income tax
Income Tax Reconciliation, Deductions
Effect of expenses deducted directly by Dr. Burzynski
Expected income tax benefit
Income Tax Reconciliation, Income Tax Expense (Benefit), at Federal Statutory Income Tax Rate
Income Tax Reconciliation, Nondeductible Expense
Nondeductible expenses and other adjustments
Change in valuation allowance
Income Tax Reconciliation, Change in Deferred Tax Assets Valuation Allowance
Income Tax Examination [Table]
Income Taxes Paid, Net
Taxes
State tax
Income Tax Reconciliation, State and Local Income Taxes
Increase (Decrease) in Accounts Payable
Accounts payable
Increase (Decrease) in Accrued Liabilities
Accrued liabilities
Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase (Decrease) in Stockholders' Equity
IRS
Internal Revenue Service (IRS) [Member]
Warrants issued for services
Issuance of Stock and Warrants for Services or Claims
Lease commitments:
Leases of Lessee Disclosure [Text Block]
Lease commitments:
Liabilities, Current
Total current liabilities
Liabilities, Current [Abstract]
Current liabilities
Liabilities
CURRENT AND TOTAL LIABILITIES
Liabilities and Equity [Abstract]
LIABILITIES AND STOCKHOLDERS' DEFICIT
Liabilities and Equity
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]
CASH FLOWS FROM FINANCING ACTIVITIES
Net Cash Provided by (Used in) Operating Activities, Continuing Operations
NET CASH USED BY OPERATING ACTIVITIES
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES
Net Cash Provided by (Used in) Continuing Operations
NET DECREASE IN CASH
Net Income (Loss) Available to Common Stockholders, Basic
NET LOSS
Net loss
Net Cash Provided by (Used in) Financing Activities, Continuing Operations
NET CASH PROVIDED BY FINANCING ACTIVITIES
Operating Expenses [Abstract]
Operating expenses
Operating Expenses
Total operating expenses
Net operating loss carry forwards available to offset future income
Operating Loss Carryforwards
Operating Income (Loss)
Operating loss before other income
BASIS OF PRESENTATION
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
BASIS OF PRESENTATION
Other Nonoperating Income
Other income
Proceeds from Contributed Capital
Contribution of capital
Property and Equipment:
Property, Plant and Equipment, Net
Property and equipment, net of accumulated depreciation of $19,509 and $18,996 at November 30, 2012 and February 29, 2012, respectively
Property, Plant and Equipment Disclosure [Text Block]
Property and Equipment:
Related Party Transactions Disclosure [Text Block]
Agreements With, and Other Related Party Transactions:
Related Party [Domain]
Agreements With, and Other Related Party Transactions:
Related Party [Axis]
Research and Development Expense
Research and development
Retained Earnings (Accumulated Deficit)
Retained deficit
Retained Earnings [Member]
Retained Deficit
Scenario, Unspecified [Domain]
Schedule of actual provision for income tax that differs from the amounts computed by applying the U.S. federal income tax rate to the pretax loss
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Granted (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
STOCK OPTIONS
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of vesting of options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
Exercise price per share (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Award Type [Domain]
Shares, Outstanding
Balance (in shares)
Balance (in shares)
Statement [Table]
Scenario [Axis]
Statement [Line Items]
Statement
STATEMENT OF STOCKHOLDERS' DEFICIT
STATEMENTS OF CASH FLOWS
Equity Components [Axis]
BALANCE SHEETS
Stock Issued During Period, Shares, Period Increase (Decrease)
Stock Issued During Period, Shares, Issued for Services
Shares issued (60,000) for services rendered pursuant to prior year obligation (in shares)
Stock options
Stock Options [Member]
Stock Issued During Period, Value, Issued for Services
Shares issued (60,000) for services rendered pursuant to prior year obligation
Stockholders' Equity Attributable to Parent [Abstract]
Stockholders' deficit
Stockholders' Equity Attributable to Parent
TOTAL STOCKHOLDERS' DEFICIT
Balance
Balance
ECONOMIC DEPENDENCY
Stockholders' Equity Note Disclosure [Text Block]
ECONOMIC DEPENDENCY
Stockholders' Equity, Period Increase (Decrease)
Subsequent Events [Text Block]
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS
Supplemental Cash Flow Information [Abstract]
SUPPLEMENTAL CASH FLOW DISCLOSURES:
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted average common shares outstanding:
Weighted Average Number of Shares Outstanding, Basic and Diluted
Weighted average number of common shares outstanding (in shares)